Share
The Endocrine Society and Keystone Symposia, a nonprofit host of conferences and symposia on a range of life science and biomedical topics, will jointly host a series of three conferences to advance endocrine research. The three conferences will focus on diabetes, oncology, and cardiovascular disease — hormone-related conditions that have a major impact on public...
Share
Endocrine Society Endorses Right to IVF Act In June 2024, the Endocrine Society endorsed the Right to IVF Act, introduced by Senators Cory Booker (D-NJ), Patty Murray (D-WA), and Tammy Duckworth (D-IL) to protect and expand nationwide access to fertility treatment, including in vitro fertilization (IVF). The Right to IVF Act would help individuals and families...
Share
By John Newell-Price, MD, PhD, President, Endocrine Society I’ve been a proud member of the Endocrine Society for more than two decades. Each year as October comes around, I renew my membership, and I really encourage you to do so too. If you haven’t already done so, now is the perfect time to renew for...
Share
An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Priority Review Granted for HER2-low or HER2-ultralow Metastatic Breast Cancer Treatment On October 1, AstraZeneca and Daiichi Sankyo announced that its supplemental Biologics License Application (sBLA) for ENHERTU® (fam-trastuzumab deruxtecan-nxki) has been accepted and granted Priority Review in the US for the...
Share
A new virtual conference will explore how artificial intelligence (AI) can help healthcare providers and scientists efficiently analyze vast amounts of data and make more informed decisions, the Endocrine Society announced today. The Society will host its first-ever Artificial Intelligence in Healthcare Virtual Summit Nov. 8-9. The event will explore AI’s potential to revolutionize patient...
Share
Injectable and gel versions of testosterone replacement therapy have long been considered cumbersome by both patients and providers, for a litany of reasons from being difficult to administer to an overwhelming insurance burden. However, research from ENDO 2024 revealed that a new oral therapy could potentially eliminate these barriers and be a safer option. By...
Share
An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * TEPEZZA Receives Approval in Japan to Treat TED On Sept. 24, Amgen announced that TEPEZZA® (JAN: Teprotumumab (Genetical Recombination)) has been approved for the treatment of active or high clinical activity score (CAS) thyroid eye disease (TED) by Japan’s Ministry of Health, Labour and Welfare (MHLW)....
Share
Pregnant women who do not get enough sleep may be at higher risk of having children with neurodevelopmental delays, according to new research published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism. Short sleep duration (SSD) is defined as sleeping less than seven hours per night. Pregnant woman may have trouble sleeping due...
